Dirk G. Brockstedt Ph.D.
Net Worth

Last updated:

What is Dirk G. Brockstedt Ph.D. net worth?

The estimated net worth of Dr. Dirk G. Brockstedt Ph.D. is at least $4,369,837 as of 5 Jan 2024. He owns shares worth $297,118 as insider, has earned $1,621,469 from insider trading and has received compensation worth at least $2,451,250 in RAPT Therapeutics, Inc..

What is the salary of Dirk G. Brockstedt Ph.D.?

Dr. Dirk G. Brockstedt Ph.D. salary is $490,250 per year as Chief Scientific Officer in RAPT Therapeutics, Inc..

How old is Dirk G. Brockstedt Ph.D.?

Dr. Dirk G. Brockstedt Ph.D. is 56 years old, born in 1969.

What stocks does Dirk G. Brockstedt Ph.D. currently own?

As insider, Dr. Dirk G. Brockstedt Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
RAPT Therapeutics, Inc. (RAPT) Chief Scientific Officer 27,820 $10.68 $297,118

What does RAPT Therapeutics, Inc. do?

RAPT Therapeutics, Inc., a clinical-stage immunology-based biopharmaceutical company, focuses on discovering, developing, and commercializing oral small molecule therapies for patients with unmet needs in oncology and inflammatory diseases. Its lead inflammation drug candidate is RPT193, a C-C motif chemokine receptor 4 (CCR4) antagonist that selectively inhibit the migration of type 2 T helper cells into inflamed tissues. The company's lead oncology drug candidate is FLX475, an oral small molecule CCR4 antagonist that is in the Phase 1/2 clinical trial to investigate as a monotherapy and in combination with pembrolizumab in patients with advanced cancer. It also focuses on the development of hematopoietic progenitor kinase 1 inhibitor. The company was formerly known as FLX Bio, Inc. and changed its name to RAPT Therapeutics, Inc. in May 2019. RAPT Therapeutics, Inc. was incorporated in 2015 and is headquartered in South San Francisco, California.

RAPT logo
RAPT
RAPT Therapeutics, Inc.
$10.68

Dirk G. Brockstedt Ph.D. insider trading

RAPT Therapeutics, Inc.

Dr. Dirk G. Brockstedt Ph.D. has made 25 insider trades between 2020-2024, according to the Form 4 filled with the SEC. Most recently he sold 898 units of RAPT stock worth $20,456 on 5 Jan 2024.

The largest trade he's ever made was exercising 9,877 units of RAPT stock on 15 May 2020. As of 5 Jan 2024 he still owns at least 27,820 units of RAPT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 898 $22.78 $20,456
Option
Employee Stock Option (right to buy) 8,000 $6.18 $49,440
Option
Common Stock 8,000 $6.18 $49,440
Sale
Common Stock 742 $21.97 $16,299
Sale
Common Stock 720 $15.05 $10,836
Option
Option (right to buy) 1,357 $6.18 $8,386
Sale
Common Stock 2,647 $23.05 $61,013
Option
Option (right to buy) 1,290 $6.18 $7,972
Option
Common Stock 2,647 $6.18 $16,358
Option
Option (right to buy) 2,648 $6.18 $16,365
Sale
Common Stock 2,648 $23.91 $63,314
Option
Common Stock 2,648 $6.18 $16,365
Option
Common Stock 2,647 $6.18 $16,358
Sale
Common Stock 2,647 $22.47 $59,478
Option
Option (right to buy) 2,647 $6.18 $16,358
Sale
Common Stock 2,648 $32.16 $85,160
Option
Common Stock 2,648 $6.18 $16,365
Option
Stock Option (right to buy) 2,648 $6.18 $16,365
Sale
Common Stock 2,647 $30.88 $81,739
Option
Common Stock 2,647 $6.3 $16,676
Option
Option (right to buy) 2,647 $6.3 $16,676
Sale
Common Stock 2,648 $35.69 $94,507
Option
Common Stock 2,648 $6.3 $16,682
Option
Option (right to buy) 2,648 $6.3 $16,682
Option
Common Stock 2,647 $6.18 $16,358
Option
Option (right to buy) 2,647 $6.18 $16,358
Sale
Common Stock 2,647 $30.78 $81,475
Option
Option (right to buy) 2,648 $6.18 $16,365
Sale
Common Stock 2,648 $6.18 $16,365
Sale
Option (right to buy) 2,648 $6.18 $16,365
Option
Option (right to buy) 2,648 $6.18 $16,365
Option
Common Stock 2,648 $35.78 $94,745
Option
Common Stock 2,647 $6.18 $16,358
Option
Option (right to buy) 2,647 $6.18 $16,358
Sale
Common Stock 2,647 $6.18 $16,358
Sale
Common Stock 2,648 N/A N/A
Option
Option (right to buy) 2,648 N/A N/A
Option
Common Stock 2,648 N/A N/A
Option
Stock Option (right to buy) 2,647 $6.18 $16,358
Sale
Common Stock 2,647 $6.18 $16,358
Option
Common Stock 2,647 $6.18 $16,358
Sale
Common Stock 2,648 N/A N/A
Option
Option (right to buy) 2,648 N/A N/A
Option
Common Stock 2,648 N/A N/A
Sale
Common Stock 2,084 $21.56 $44,931
Sale
Common Stock 9,877 $21.22 $209,590
Option
Common Stock 9,877 $6.24 $61,632
Option
Option (right to buy) 9,877 $6.24 $61,632
Sale
Common Stock 1,179 $19.68 $23,203
Sale
Common Stock 821 $19.76 $16,225
Option
Common Stock 9,300 $6.18 $57,474
Option
Stock Option (right to buy) 9,300 $6.18 $57,474
Sale
Common Stock 9,877 $17.01 $168,008
Option
Stock Option (right to buy) 9,877 N/A N/A
Option
Stock Option (right to buy) 9,877 $6.24 $61,632
Option
Common Stock 9,877 N/A N/A
Option
Common Stock 9,877 $6.24 $61,632
Sale
Common Stock 1,910 $28.06 $53,595
Sale
Common Stock 9,877 $23.6 $233,097
Sale
Common Stock 9,877 $23.6 $233,097
Option
Stock Option (right to buy) 9,877 $6.18 $61,040
Option
Common Stock 9,877 $6.18 $61,040
Option
Common Stock 9,877 N/A N/A
Option
Stock Option (right to buy) 9,877 N/A N/A
Sale
Common Stock 9,877 N/A N/A

RAPT Therapeutics key executives

RAPT Therapeutics, Inc. executives and other stock owners filed with the SEC: